Referencias

-A A +A

Referencias

1. Wolff K. Fitzpatrick Dermatología en Medicina General. Buenos Aires: Editorial Médica Panamericana; 2009. p. 65-7.
2. Chuh AA, Dofitas BL, Comisel G, Reveiz L, Sharma V, Garner SE, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007. Fecha de consulta: 16 de abril de 2018. Disponible en: http://doi.wiley.com/10.1002/14651858.CD005068.pub2.
3. Nair PA, Bhimji SS. Pityriasis rosea. Stat Pearls. 2018. Fecha de consulta: 27 de junio de 2018. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK448091/
4. Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82-5.
5. Goldstein A, Goldstein BG, Delavalle R. Pityriasis rosea - UpToDate. Fecha de consulta: 16 de abril de 2018. Disponible en: https://www.uptodate.com/contents/pityriasis-rosea.
6. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collab. 2011. Fecha de consulta: 27 de junio de 2018. Disponible en: https://es.cochrane.org/sites/es.cochrane.org/files/public/uploads/Manua....
7. Moher D, Liberati A, Tetzlaff J, Altman DG. Academia and clinic preferred reporting items for systematic reviews and meta-analyses. Ann Intern Med. 2009;151:264-9.
8. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s Dermatology in General Medicine. 8 th edition. New York: McGrawHill Medical; 2012 Cap 42. Fecha de consulta: 27 de junio de 2018. Disponible en: https://accessmedicine.mhmedical.com/book.aspx?bookID=392
9. Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. World J Clin Cases. 2017;5:203.
10. Chuh A, Zawar V, Sciallis G, Kempf W. A position statement on the management of patients with pityriasis rosea. J Eur Acad Dermatology Venereol. 2016;30:1670-81.
11. Singh S, Anurag, Tiwary N. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. Indian J Dermatology Venereol Leprol. 2016;82:505.
12. Ganguly S. A randomized, double-blind, placebocontrolled study of efficacy of oral acyclovir in the treatment of Pityriasis rosea. J Clin Diagnostic Res. 2014;8:1-4.
13. Rassai S, Feily A, Sina N, Abtahian S. Low dose of acyclovir may be an effective treatment against pityriasis rosea: A random investigator-blind clinical trial on 64 patients. J Eur Acad Dermatology Venereol. 2011;25:24-6.
14. Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82-5.
15. Amatya A, Rajouria EA, Karn DK. Comparative study of effectiveness of oral Acyclovir with oral erythromycin in the treatment of pityriasis rosea. Kathmandu Univ Med J. 2012;10:57-61.
16. Noormohammadpour P, Toosi S, Hosseinpour A, Hosseini M, Sayanjali S, Ehsani A, et al. The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea. Indian J Dermatol. 2010;55:246.
17. Sharma P, Yadav T, Gautam R, Taneja N, Satyanarayana L. Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial. J Am Acad Dermatol. 2000;42:241-4.
18. Ahmed N, Iftikhar N, Bashir U, Rizvi SDA, Sheikh ZI, Manzur A. Efficacy of clarithromycin in pityriasis rosea. J Coll Physicians Surg Pak. 2014;24:802-5.
19. Pandhi D, Singal A, Verma P, Sharma R. The efficacy of azithromycin in pityriasis rosea: A randomized, double-blind, placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2014;80:36.
20. Amer A. Azithromycin does not cure pityriasis rosea. Pediatrics. 2006;117:1702-5.
21. Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: A bilateral comparison study. J Am Acad Dermatol. 1995;33:996-9.
22. Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasis rosea with UV radiation. Arch Dermatol. 1983;119:381-2.
23. Sonthalia S, Kumar A, Zawar V, Priya A, Yadav P, Srivastava S, et al. Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. J Dermatolog Treat. 2018; 617-622.

PATROCINADORES PRINCIPALES

  • MEDIHEALTH
  • SESDERMA
  • MD FARMACIA MAGISTRAL
  • EPIDERMIQUE
  • ISDIN
  • GALDERMA